Iosif Taleb1, James Wever-Pinzon1, Wenyan Wang2, Antigone Koliopoulou3, Elizabeth Dranow3, Tao Yu2, Lixue Yin2, Stephen H McKellar1, Josef Stehlik1, James C Fang3, Omar Wever-Pinzon1, Craig H Selzman3, Stavros G Drakos4. 1. University of Utah Healthcare and School of Medicine, Salt Lake City, UT, USA; Veterans Affairs Medical Center, Salt Lake City, UT, USA. 2. Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, Sichuan, China. 3. University of Utah Healthcare and School of Medicine, Salt Lake City, UT, USA. 4. University of Utah Healthcare and School of Medicine, Salt Lake City, UT, USA; Veterans Affairs Medical Center, Salt Lake City, UT, USA. Electronic address: stavros.drakos@hsc.utah.edu.
Abstract
BACKGROUND: Studies have indicated differences between Asians and Whites in their propensity for stroke, coronary artery disease, heart failure, bleeding and thrombosis. We investigated whether Asian-Americans on durable left ventricular assist devices (LVADs) exhibit differential morbidity and mortality when compared to Whites. METHODS: We analysed prospectively collected data from the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) database to compare the outcomes after LVAD implantation of Asians versus Whites. RESULTS: In total, 7,018 patients were included, 130 were identified as Asian-Americans. Asian-Americans were younger, had lower body mass index, higher serum bilirubin and lower albumin levels. In a multivariable regression model, there was no difference in survival between the two groups. Asian-Americans had lower incidence of device malfunction and after adjusting for multiple factors this remained lower. The adjusted risk of a major safety composite outcome, including major bleeding, major infection, stroke and device malfunction, revealed no difference between the two groups. CONCLUSIONS: Although prior studies have reported worse cardiac surgery outcomes in Asians, in this INTERMACS analysis Asian-Americans appear to have similar survival and risk of adverse events as their White counterparts. The incidence of device malfunction was lower in the Asian-Americans, both in a univariate model and after adjusting for multiple clinical factors. Future, larger studies of Asian-Americans with end-stage heart failure and LVAD support are warranted to confirm these results.
BACKGROUND: Studies have indicated differences between Asians and Whites in their propensity for stroke, coronary artery disease, heart failure, bleeding and thrombosis. We investigated whether Asian-Americans on durable left ventricular assist devices (LVADs) exhibit differential morbidity and mortality when compared to Whites. METHODS: We analysed prospectively collected data from the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) database to compare the outcomes after LVAD implantation of Asians versus Whites. RESULTS: In total, 7,018 patients were included, 130 were identified as Asian-Americans. Asian-Americans were younger, had lower body mass index, higher serum bilirubin and lower albumin levels. In a multivariable regression model, there was no difference in survival between the two groups. Asian-Americans had lower incidence of device malfunction and after adjusting for multiple factors this remained lower. The adjusted risk of a major safety composite outcome, including major bleeding, major infection, stroke and device malfunction, revealed no difference between the two groups. CONCLUSIONS: Although prior studies have reported worse cardiac surgery outcomes in Asians, in this INTERMACS analysis Asian-Americans appear to have similar survival and risk of adverse events as their White counterparts. The incidence of device malfunction was lower in the Asian-Americans, both in a univariate model and after adjusting for multiple clinical factors. Future, larger studies of Asian-Americans with end-stage heart failure and LVAD support are warranted to confirm these results.
Authors: E A Rose; A C Gelijns; A J Moskowitz; D F Heitjan; L W Stevenson; W Dembitsky; J W Long; D D Ascheim; A R Tierney; R G Levitan; J T Watson; P Meier; N S Ronan; P A Shapiro; R M Lazar; L W Miller; L Gupta; O H Frazier; P Desvigne-Nickens; M C Oz; V L Poirier Journal: N Engl J Med Date: 2001-11-15 Impact factor: 91.245
Authors: Latha P Palaniappan; Maria Rosario G Araneta; Themistocles L Assimes; Elizabeth L Barrett-Connor; Mercedes R Carnethon; Michael H Criqui; Gordon L Fung; K M Venkat Narayan; Hamang Patel; Ruth E Taylor-Piliae; Peter W F Wilson; Nathan D Wong Journal: Circulation Date: 2010-08-23 Impact factor: 29.690
Authors: James K Kirklin; Francis D Pagani; Robert L Kormos; Lynne W Stevenson; Elizabeth D Blume; Susan L Myers; Marissa A Miller; J Timothy Baldwin; James B Young; David C Naftel Journal: J Heart Lung Transplant Date: 2017-07-15 Impact factor: 10.247
Authors: John J Atherton; Christopher S Hayward; Wan Azman Wan Ahmad; Bernard Kwok; Jesus Jorge; Adrian F Hernandez; Li Liang; Robb D Kociol; Henry Krum Journal: J Card Fail Date: 2011-10-08 Impact factor: 5.712
Authors: Arthur L Klatsky; Gary D Friedman; Stephen Sidney; Harald Kipp; Ai Kubo; Mary Anne Armstrong Journal: Neuroepidemiology Date: 2005-04-25 Impact factor: 3.282
Authors: Carolyn S P Lam; Tiew-Hwa Katherine Teng; Wan Ting Tay; Inder Anand; Shu Zhang; Wataru Shimizu; Calambur Narasimhan; Sang Weon Park; Cheuk-Man Yu; Tachapong Ngarmukos; Razali Omar; Eugene B Reyes; Bambang B Siswanto; Chung-Lieh Hung; Lieng H Ling; Jonathan Yap; Michael MacDonald; A Mark Richards Journal: Eur Heart J Date: 2016-08-07 Impact factor: 29.983
Authors: Joseph G Rogers; Javed Butler; Steven L Lansman; Alan Gass; Peer M Portner; Michael K Pasque; Richard N Pierson Journal: J Am Coll Cardiol Date: 2007-08-06 Impact factor: 24.094